Items 51 to 58 of 58 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Diclofenac acid | 15307-86-5 | sc-357332 sc-357332A | 5 g 25 g | $109.00 $298.00 | 5 | |
Diclofenac acid exhibits distinctive characteristics as a non-steroidal anti-inflammatory compound, primarily through its selective inhibition of cyclooxygenase enzymes. Its structural features enable strong interactions with the enzyme's active site, leading to competitive inhibition. The presence of a phenyl ring enhances lipophilicity, facilitating membrane permeability. Additionally, the compound's ability to form hydrogen bonds with amino acid residues contributes to its binding affinity, influencing the overall dynamics of arachidonic acid metabolism. | ||||||
4′-Hydroxy Diclofenac-13C6 | 1189656-64-1 | sc-217053 | 1 mg | $686.00 | ||
4'-Hydroxy Diclofenac-13C6 exhibits distinctive characteristics in its interaction with cyclooxygenase (Cox) enzymes, primarily due to its deuterated structure, which allows for precise isotopic tracing in metabolic studies. The hydroxyl group enhances hydrogen bonding, influencing the compound's affinity for enzyme active sites. Its unique isotopic composition alters reaction kinetics, providing insights into metabolic pathways and enzyme selectivity, while its solubility profile facilitates diverse biochemical interactions. | ||||||
7Z,10Z,13Z,16Z,19Z-Docosapentaenoic acid | 24880-45-3 | sc-200786 sc-200786A sc-200786B | 1 mg 10 mg 50 mg | $91.00 $148.00 $265.00 | ||
7Z,10Z,13Z,16Z,19Z-Docosapentaenoic acid exhibits distinctive molecular interactions as a Cox inhibitor, characterized by its polyunsaturated structure that enhances fluidity and flexibility. This unique configuration allows for effective integration into lipid bilayers, influencing membrane dynamics. Its multiple double bonds facilitate specific hydrogen bonding and hydrophobic interactions, which can modulate enzyme conformation and activity, thereby impacting metabolic pathways and signaling cascades. | ||||||
Phenylbutazone-d9 | 1189479-75-1 | sc-219606 | 2.5 mg | $510.00 | ||
Phenylbutazone-d9 showcases unique molecular behavior as a Cox inhibitor, characterized by its deuterated isotopes that facilitate advanced kinetic studies. The presence of deuterium alters the vibrational frequencies of the molecule, impacting its interaction dynamics with the enzyme. This modification enhances the precision of binding affinity assessments and metabolic tracking, while its structural features promote specific conformational changes that influence enzyme activity and selectivity in biochemical pathways. | ||||||
DuP-697 | 88149-94-4 | sc-200680 sc-200680A | 5 mg 25 mg | $150.00 $500.00 | ||
DuP-697 functions as a selective Cox inhibitor, showcasing unique molecular interactions due to its specific structural features. Its design allows for preferential binding to the cyclooxygenase enzyme, altering the active site conformation. This selective affinity influences reaction kinetics, leading to a distinct modulation of prostaglandin synthesis. Additionally, its hydrophobic regions enhance interactions with lipid environments, potentially affecting membrane-associated processes and enzyme accessibility. | ||||||
7-(Trifluoromethyl)1H-indole-2,3-dione | 391-12-8 | sc-217411 | 100 mg | $330.00 | ||
7-(Trifluoromethyl)1H-indole-2,3-dione exhibits distinctive characteristics as a cyclooxygenase inhibitor, primarily through its trifluoromethyl group, which enhances electron-withdrawing effects. This modification alters the electronic distribution within the molecule, facilitating stronger interactions with the enzyme's active site. The compound's planar structure promotes π-π stacking interactions, potentially influencing enzyme dynamics and stability. Its unique solubility profile may also affect its distribution in biological systems, impacting overall reactivity and selectivity. | ||||||
(E)-3,5,4′-Tribenzyloxystilbene | 89946-06-5 | sc-474967 | 1 g | $380.00 | ||
(E)-3,5,4'-Tribenzyloxystilbene demonstrates unique properties as a cyclooxygenase inhibitor, characterized by its extensive benzyl ether substitutions. These bulky groups enhance steric hindrance, influencing the compound's binding affinity and selectivity towards the enzyme. The molecule's conjugated system allows for significant resonance stabilization, which may modulate its reactivity. Additionally, its hydrophobic nature can affect membrane permeability and interaction with lipid environments, further impacting its biological behavior. | ||||||
[3,4-Bis-(4-methoxyphenyl)isoxazol-5-yl]-acetic acid | 78967-07-4 | sc-313584A sc-313584 | 100 mg 250 mg | $153.00 $245.00 | ||
[3,4-Bis-(4-methoxyphenyl)isoxazol-5-yl]-acetic acid is distinguished by its isoxazole core, which facilitates unique electronic interactions due to the presence of nitrogen and oxygen atoms. This compound exhibits strong dipole-dipole interactions, enhancing its solubility in various solvents. Its aromatic methoxy substituents contribute to increased electron density, promoting electrophilic reactivity. The compound's structural rigidity allows for selective binding in complexation reactions, influencing its kinetic behavior in synthetic applications. | ||||||